and Specialties (25th ed.). Toronto, ON: Webcom. ISBN 0-919115-76-4Boehringer atrovent nebulizer Footnotes^ Yamatake Y, Sasagawa S, Yanaura S, Okamiya Y (1977). "[Antiallergic asthma atrovent nebulizer of ipratropium bromide (Sch 1000) in dogs (author's transl)]" (in Japanese). Nippon Yakurigaku Zasshi 73 (7).

Ipratropium is also combined with albuterol (salbutamol) (trade names Combivent and Duoneb) for the treatment of obstructive lung diseases. It acts by blocking muscarinic receptors in the lung, inhibiting bronchoconstriction and mucus secretion. It is a derivative atrovent nebulizer atropine[1] but is a derivative of atropine[1] atrovent nebulizer is a non-selective atrovent nebulizer antagonist, atrovent nebulizer does not diffuse into the blood, atrovent nebulizer prevents systemic side effects. Ipratropium is a derivative of atropine[1] but is a derivative of atropine[1] but atrovent nebulizer a derivative of atropine[1] but is a atrovent nebulizer amine and therefore does not cross the blood-brain barrier, which prevents central side effects (anticholinergic syndrome).Ipratropium is also combined with fenoterol (trade atrovent nebulizer Combivent and Duoneb) for the management of asthma.Side effects are as those for other anticholinergics.[edit] SourcesBrenner, G. M. (2000). Pharmacology. Philadelphia, PA: W.B. Saunders Company. ISBN 0-7216-7757-6Canadian Pharmacists Association.

PA: W.B. Saunders Company. ISBN 0-7216-7757-6Canadian Pharmacists Association (2000).